Scutellarin Reduces Cerebral Ischemia Reperfusion Injury Involving in Vascular Endothelium Protection and PKG Signal

Flavonoid glycoside scutellarin (SCU) has been widely applied in the treatment of cerebral ischemic diseases in China. In this article, we conducted research on the working mechanisms of SCU in hypoxia reoxygenation (HR) injury of isolated cerebral basilar artery (BA) and erebral ischemia reperfusio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ya-Juan, Chen, Chen, Li, Meng-Yuan, Li, Qing-Qing, Zhang, Xiu-Juan, Huang, Rong, Zhu, Xing-Wei, Bai, Chun-Yun, Zhang, Liu-Yi, Peng, Pei-Hua, Yang, Wei-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599605/
https://www.ncbi.nlm.nih.gov/pubmed/34750765
http://dx.doi.org/10.1007/s13659-021-00322-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599605/
https://www.ncbi.nlm.nih.gov/pubmed/34750765
http://dx.doi.org/10.1007/s13659-021-00322-z

Ejemplares similares